research Systemic Treatment with a KLK5 Inhibitor Shows Efficacy in a Murine Model of Netherton Syndrome July 2024 in “Journal of Investigative Dermatology” A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.